Through Exquisite Control
Serious diseases can result if the immune system consistently under- or over-responds. Our first-in-class medicines precisely control immune responses in patients with inflammatory or autoimmune disorders, and enhance responses in patients with cancer.
A Leading Portfolio of
First-in-Class Small Molecules
We are working with urgency to develop novel drugs that meet the needs of patients with inflammatory disorders and cancer.